Kevin G. Shaw Net Worth

What's Kevin Shaw's mailing address?

Kevin's mailing address filed with the SEC is C/O NEXTCURE, INC., 9000 VIRGINIA MANOR ROAD, SUITE 200, BELTSVILLE, MD, 20705.

Insiders trading at Nextcure Inc

Over the last 6 years, insiders at Nextcure Inc have traded over $0 worth of Nextcure Inc stock and bought 1,475,000 units worth $25,387,500 . The most active insiders traders include Advisors Llc Orbi Med Capit..., Chau Quang Khuong e Timothy M Shannon. On average, Nextcure Inc executives and independent directors trade stock every 48 days with the average trade being worth of $233,653. The most recent stock trade was executed by Kevin N. Heller on 14 July 2020, trading 27,229 units of NXTC stock currently worth $48,195.

What does Nextcure Inc do?

nextcure, inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. its lead product candidate is nc318, which is in phase 2 clinical trials for the treatment of advanced or metastatic solid tumors. the company is also developing nc410, is a novel immunomedicine designed to block immune suppression mediated by an immune modulator called leukocyte-associated immunoglobulin-like receptor 1. its discovery and research programs include an antibody in preclinical evaluation of other potential novel immunomodulatory molecules that targets a novel member of the b7-family of immunomodulatory proteins; and an antibody in preclinical development targeting an immune modulator that is expressed in inflamed tissue and the tumor microenvironment in various tumor types. nextcure, inc. has a license agreement with yale university; and a research and development col

Nextcure Inc executives and stock owners

Nextcure Inc executives and other stock owners filed with the SEC include:

• Steven Cobourn,
  Chief Financial Officer
• Michael S. Richman MSBA,
  Co-Founder, CEO, Pres & Director
• Michael S. Richman,
  Co-Founder, CEO, Pres & Director
• Michael Richman,
  President, Chief Executive Officer, Director
• Sol Langermann,
  Chief Scientific Officer
• Dr. Solomon Langermann Ph.D.,
  Chief Scientific Officer
• David Kabakoff,
  Independent Chairman of the Board
• Stephen Webster,
  Independent Director
• Briggs Morrison,
  Independent Director
• Timothy Mayer,
  Chief Operating Officer
• Chau Khuong,
  Independent Director
• Elaine Jones,
  Independent Director
• Stella Xu,
  Independent Director
• John Houston,
  Director
• Garry Nicholson,
  Independent Director
• Linda Liu,
  Senior Vice President - Research
• James Bingham,
  Chief Development Officer
• Sourav Kundu Ph.D.,
  Sr. VP of Devel. & Manufacturing
• Dr. Han Myint FACP, M.D.,
  Chief Medical Officer
• Dr. Timothy Mayer Ph.D.,
  Chief Operating Officer
• Steven P. Cobourn CPA, CPA,
  Chief Financial Officer
• Dr. Lieping Chen M.D., Ph.D.,
  Co-Founder & Chairman of Scientific Advisory Board
• Kevin N. Heller,
  Chief Medical Officer
• Venture Partners Ix, L.P.So...,
  
• Advisors Llc Orbi Med Capit...,
  
• X L.P.Canaan Partners X Llc...,
  
• Timothy M Shannon,
  Director
• Judith Li,
  Director
• Anne Elizabeth Borgman,
  
• Ellen Feigal,
  
• Sourav Kundu,
  Sr VP, Dev. & Mfg.
• Han Myint,
  Chief Medical Officer
• Kevin G. Shaw,
  Sr VP, General Counsel